Showing results (11-20 of 356) with videos related to
Sort By:
Pageof 36
Innovative Surgical Sciences|October 4, 2019
First-line molecular therapies in the treatment of metastatic colorectal cancer - a literature-based review of phases II and III trialsArndt Vogel, Martha M KirsteinDigestive Diseases (Basel, Switzerland)|July 19, 2014
The pathogenesis of hepatocellular carcinomaMartha M Kirstein, Arndt VogelTrends in Cancer|November 29, 2021
Combination therapies for targeting FGFR2 fusions in cholangiocarcinomaAnna Saborowski, Arndt Vogel, Oreste SegattoTherapeutic Advances in Medical Oncology|September 28, 2020
FGFR inhibitors in cholangiocarcinoma: what's now and what's next?Anna Saborowski, Ulrich Lehmann, Arndt VogelExpert Opinion on Investigational Drugs|December 31, 2020
Immunotherapies in clinical development for biliary tract cancerArndt Vogel, Melanie Bathon, Anna SaborowskiExpert Review of Anticancer Therapy|January 27, 2021
Advances in systemic therapy for the first-line treatment of unresectable HCCArndt Vogel, Melanie Bathon, Anna SaborowskiCurrent Cancer Drug Targets|August 10, 2012
mTor as a potential target for the prevention and treatment of hepatocellular carcinomaLaura Elisa Buitrago-Molina, Arndt VogelOncoimmunology|October 24, 2014
Of microspheres and microbes: A double-hit strategy for cancer immunotherapyBenjamin Brinkhoff, Thomas C WirthFrontiers in Immunology|January 10, 2018
Neoantigen Targeting-Dawn of a New Era in Cancer Immunotherapy?Thomas C Wirth, Florian KühnelAdvances in Experimental Medicine and Biology|July 30, 2017
Molecular Pathogenesis of Liver Injury in Hereditary Tyrosinemia 1Robert M Tanguay, Francesca Angileri, Arndt VogelPageof 36